跳至主要内容
临床试验/IRCT2017070234844N1
IRCT2017070234844N1招募中2 期

Comparing the Atomoxetine effectiveness in retention of patients in the stimulant (Meth-Amphethamine) dependence treatment with placebo in a three month period

Tehran University of Medical Sciences (TUMS), Vice-chancellor for Research0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • 1- Diagnosis of methamphetamine use disorder based on DSM-5; 2- Using methamphetamine 2 times or more in week during last month; 3- Age: 18 to 60 years old; 4. Referring to Psychiatric Clinic of Roozbeh Hospital or Iranian National Center for Addiction Studies (INCAS) Clinic
  • Exclusion criteria:
  • 1. Sensitivity to Atomoxetine; 2. Rising liver enzymes more than three times; Hepatic failure, acute hepatitis; 3. Other substance use disorders including alcohol, opioids and sedative and hypnotic medications (except nicotine); 4. More than 2 times illicit opioid use during last month; 5. Use of mono-amine oxidase inhibitor (MAOI) medications during last 2 weeks; 6. Severe cardiac disorder, history of MI during last month, uncontrolled hypertension (HTN); 7.Pregnancy or breastfeeding; 8. Risk of suicide, homicide or violence; 9. Psychosis; 10.
  • Unable to comprehend study protocol and answer questionnaires; 11. Receiving
  • opioid agonist medications such as MMT.

排除标准

  • 未提供

研究者

发起方
Tehran University of Medical Sciences (TUMS), Vice-chancellor for Research

相似试验